[Table/Fig-4]:

Passman et al., criteria for completeness of reporting for possible amiodarone-associated optic neuropathy cases

	Data Elements	Scoring (based on number of elements reported)
Optic neuropathy diagnosis (1 point for each element)	Optic disc oedema, visual field defect, color vision abnormalities, optic disc atrophy, optic disc haemorrhages, afferent pupillary defect, intracranial hypertension, and change in visual acuity/subjective blurring of vision	Complete (6-8) Partially complete (3-5) Incomplete (<3)
Association with amiodarone (1 point for each element)	Dose, duration of treatment, duration of treatment before presentation, other simultaneous drug therapy, outcome post- discontinuation, change in visual acuity after initiation of amiodarone	Complete (5-6) Partially complete (3-4) Incomplete (<3)
Diagnostic certainty	Completeness of information provided and the diagnosis given by the reporting physician	Probable (patient was diagnosed with optic neuropathy/neuritis) Possible (patient had one or more features suggestive of optic neuropathy/neuritis) Incomplete (no information is present on the final diagnosis or the presence or absence of features suggestive of optic neuropathy /neuritis)